Source: Annual Congress 2008 - Pulmonary hypertension I
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
I. Blanco, M. T. Melgosa, G. Ricci, J. C. Garcia-Pagan, P. Escribano, F. Burgos, J. Roca, R. Rodriguez-Roisin, J. Bosch, J. A. Barbera (Barcelona, Madrid, Spain; Rome, Italy). Iloprost treatment in portopulmonary hypertension. Eur Respir J 2008; 32: Suppl. 52, 1017

Member's Comments

No comment yet.

Related content which might interest you: Sildenafil treatment for portopulmonary hypertension Source: Eur Respir J 2006; 28: Suppl. 50, 651s Year: 2006 Experience with inhaled iloprost and bosentan in portopulmonary hypertension Source: Eur Respir J 2007; 30: 1096-1102 Year: 2007 Sildenafil treatment for portopulmonary hypertension Source: Eur Respir J 2006; 28: 563-567 Year: 2006 Inhaled iloprost for patients with portopulmonary hypertension Source: Eur Respir J 2003; 22: Suppl. 45, 462s Year: 2003 Acute effects of inhaled iloprost in portopulmonary hypertension Source: Eur Respir J 2006; 28: Suppl. 50, 547s Year: 2006 Development of hepatopulmonary syndrome during combination therapy for portopulmonary hypertension Source: Eur Respir J, 53 (1) 1801880; 10.1183/13993003.01880-2018 Year: 2019 Long-term outcome of patients with portopulmonary hypertension treated with sildenafil Source: Annual Congress 2009 - Pulmonary hypertension Year: 2009 Sildenafil for patients with portopulmonary hypertension, candidates to hepatic transplant Source: Eur Respir J 2004; 24: Suppl. 48, 109s Year: 2004 Long-term treatment of pulmonary hypertension with aerosolized iloprost Source: Eur Respir J 2001; 17: 8-13 Year: 2001 Efficacy, safety and pharmacokinetics of bosentan in portopulmonary hypertension Source: Eur Respir J 2013; 41: 96-103 Year: 2013 Sildenafil and aerolized iloprost treatment in two cases with primary pulmonary hypertension Source: Eur Respir J 2005; 26: Suppl. 49, 520s Year: 2005 Portopulmonary hypertension Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-39-1, page=129 Year: 2005 Bosentan therapy for portopulmonary hypertension Source: Eur Respir J 2005; 25: 502-508 Year: 2005 Ambrisentan for therapy of portopulmonary hypertension (POPH): Update on safety and efficacy Source: Annual Congress 2012 - Pulmonary circulation: clinical PAH, registries and treatments Year: 2012 Initial combination therapy with epoprostenol and bosentan in severe pulmonary arterial hypertension Source: Annual Congress 2009 - Pulmonary arterial hypertension Year: 2009 Intravenous iloprost bridging to orthotopic liver transplantation in portopulmonary hypertension Source: Eur Respir J 2004; 24 : 703-707 Year: 2004 How should we treat portopulmonary hypertension? Source: Eur Respir J 2006; 28: 466-467 Year: 2006 Portopulmonary hypertension Source: Virtual Congress 2021 – Pulmonary vascular diseases Year: 2021 Intravenous iloprost for treatment failure of aerosolised iloprost in pulmonary arterial hypertension Source: Eur Respir J 2002; 20: 339-343 Year: 2002 Bosentan added to sildenafil therapy in patients with pulmonary arterial hypertension Source: Eur Respir J 2015; 46: 405-413 Year: 2015